Holen Sie sich die Stockscreener-App
1.495
1.66%
-0.015
Cocrystal Pharma Inc Aktie (COCP) Neueste Nachrichten
Why Cocrystal Pharma Shares Are Cooling Off Monday? - Benzinga
Cocrystal Pharma, Inc. (COCP) stock price, news, quote and history - Yahoo Finance UK
COCP PE Ratio & Valuation, Is COCP Overvalued - Intellectia AI
We're Keeping An Eye On Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Rate - Yahoo Finance
Shares +48% after hours: COCP Cocrystal Pharma NASDAQ 03 Apr earnings spotlight - meyka.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
Crude Oil Rises Sharply; Acuity Shares Fall After Q2 Results - Sahm
Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988 - Sahm
Cocrystal Pharma (COCP) Receives FDA Fast Track Status for Norov - GuruFocus
Cocrystal Pharma stock surges on FDA Fast Track designation - Investing.com
Cocrystal Pharma stock surges on FDA Fast Track designation By Investing.com - Investing.com Canada
Cocrystal Pharma, Inc. (8CC.F) stock price, news, quote and history - Yahoo Finance UK
Nasdaq Down 1%; US Initial Jobless Claims Fall - Benzinga
Cocrystal Pharma Advances in Norovirus Study as Financial Challenges Loom - StocksToTrade
Cocrystal Pharma Wins FDA Fast Track for Norovirus Drug - TipRanks
COCP Stock Soars 75% — What Is The Link To Cocrystal’s Norovirus Treatment? - Stocktwits
Cocrystal Pharma Advances Antiviral Trials Amid Financial Strategy Shift - timothysykes.com
FDA Fast Track backs Cocrystal (Nasdaq: COCP) oral norovirus antiviral CDI-988 - Stock Titan
Cocrystal Pharma, Inc. announced that its antiviral candidate drug Cdi-988 has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA). - Bitget
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive - Yahoo Finance
COCP Stock Price, Quote & Chart | COCRYSTAL PHARMA INC (NASDAQ:COCP) - ChartMill
COCP gets FDA Fast Track for CDI-988 norovirus drug, stock up 75% | Tap to know more | Inshorts - Inshorts
Cocrystal begins norovirus challenge study, reports 2025 results By Investing.com - Investing.com South Africa
Cocrystal Pharma Reports 2025 Financial Results and Advances Norovirus and Influenza Antiviral Drug Pipeline - Minichart
Cocrystal Pharma 2025 Research and Development Expenses $5.1M >COCP - Moomoo
Cocrystal Pharma Reports 2025 Financial Results, Advances Antiviral Drug Programs - National Today
Cocrystal Pharma Reports 2025 Financial Results - National Today
[10-K] Cocrystal Pharma, Inc. Files Annual Report - Stock Titan
Cocrystal begins norovirus challenge study, reports 2025 results - Investing.com
Cocrystal Pharma 2025 10-K: $0 Revenue, $(0.78) EPS, $(8.83)M Net Loss - TradingView
Cocrystal Pharma reports 2025 net loss $8.8M, cash $7.7M, advances norovirus CDI-988 into Phase 1b - TradingView
Cocrystal Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Cocrystal Pharma (NASDAQ: COCP) cuts 2025 loss to $8.8M and advances antivirals - Stock Titan
Cocrystal Pharma, Inc. recently released its financial report for fiscal year 2025 and provided an update on the latest progress in its antiviral drug development projects. - Bitget
Cocrystal Pharma 2025 net loss narrows as R&D expenses fall - TradingView
BRIEF-Cocrystal Pharma FY Net Income USD -8.831 Million - TradingView
Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs - GlobeNewswire
Institution Moves: Can Cocrystal Pharma Inc ride the EV waveEarnings Recap Report & Real-Time Volume Surge Alerts - baoquankhu1.vn
Insider Buy: Is Cocrystal Pharma Inc stock technically oversold2026 Spike Watch & Verified Swing Trading Watchlists - baoquankhu1.vn
Cocrystal Pharma Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
If You Invested $1,000 in Cocrystal Pharma Inc (COCP) - Stock Titan
COCP SEC FilingsCocrystal Pharma Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Levels: Can Cocrystal Pharma Inc keep up with sector leaders2026 Update & High Conviction Buy Zone Alerts - baoquankhu1.vn
Cocrystal Pharma Announces Passing of Board Member Japour - The Globe and Mail
Cocrystal begins dosing patients in norovirus challenge study - Investing.com Nigeria
Cocrystal Pharma, Inc. Announces Passing of Board Member Dr. Anthony Japour in March 2026 9 - Minichart
Cocrystal Pharma (COCP) reports death of board director Japour - Stock Titan
Why is Cocrystal Pharma Inc stock going up2026 Bull vs Bear & Real-Time Price Movement Reports - baoquankhu1.vn
COCP|Cocrystal Pharma Inc|Price:1.030|Chg%:-0.03 - TradingKey
Cocrystal begins dosing patients in norovirus challenge study By Investing.com - Investing.com South Africa
Can Cocrystal Pharma Inc keep up with sector leadersWall Street Watch & Real-Time Buy Signal Notifications - baoquankhu1.vn
Cocrystal Pharma Doses First Subjects in Phase 1b Trial of CDI-988 Oral Antiviral for Norovirus Prevention and Treatment - Minichart
First Subjects Dosed in Cocrystal Pharma's Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment - Bitget
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):